LON:HZD - Horizon Discovery Group Share Price, Forecast & News

Horizon Discovery Group trades on the London Stock Exchange (LON) under the ticker symbol "HZD."

3 brokerages have issued twelve-month price objectives for Horizon Discovery Group's shares. Their forecasts range from GBX 170.80 to GBX 280. On average, they expect Horizon Discovery Group's share price to reach GBX 207.20 in the next year. This suggests a possible upside of 38.4% from the stock's current price. View Analyst Price Targets for Horizon Discovery Group.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horizon Discovery Group in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Horizon Discovery Group.

News headlines about HZD stock have trended extremely negative this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Horizon Discovery Group earned a news impact score of -5.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Horizon Discovery Group.

Some companies that are related to Horizon Discovery Group include Paradigm Biopharmaceuticals (PAR), BELLUS Health (BLU), Oxford BioMedica (OXB), CEL-SCI (CVM), Cel-Sci (CVM), Bellus Health (BLU), Starpharma (SPL), Biotest (BIO), Pfenex (PFNX), TELIX Pharmaceutical (TLX), Neptune Wellness Solutions (NEPT), Pfenex (PFNX), Rafael (RFL), ProMetic Life Sciences (PLI) and Silence Therapeutics (SLN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Discovery Group investors own include Flowgroup (FLOW), Faron Pharmaceuticals Oy (FARN), Crispr Therapeutics (CRSP), Yamana Gold (YRI), Barkerville Gold Mines (BGM), Games Workshop Group (GAW), Polo Resources (POL), Celgene (CELG), 22nd Century Group (XXII) and Eldorado Gold (ELD).

Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of HZD stock can currently be purchased for approximately GBX 149.70.

Horizon Discovery Group has a market capitalization of £225.20 million and generates £62.18 million in revenue each year. Horizon Discovery Group employs 288 workers across the globe.View Additional Information About Horizon Discovery Group.

The official website for Horizon Discovery Group is http://www.horizondiscovery.com/.

Horizon Discovery Group's mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000.